TY - JOUR
T1 - Water-restraint stress enhances methamphetamine-induced cardiotoxicity
AU - Tomita, Masafumi
AU - Katsuyama, Hironobu
AU - Watanabe, Yoko
AU - Hidaka, Kazuo
AU - Yoshitome, Kei
AU - Miyaishi, Satoru
AU - Ishikawa, Takaki
AU - Shinone, Kotaro
AU - Nata, Masayuki
N1 - Funding Information:
We thank Ms. T. Okuyama, S. Fushimi, Y. Yoshida and K. Wakabayashi for their technical assistance of the study. This work was supported by KAKENHI (No. 21590735, 22590644) and by Research Project Grant (No. 22-A64) from Kawasaki Medical School.
PY - 2011/3/15
Y1 - 2011/3/15
N2 - Methamphetamine (MAP) and stress both cause a variety of cardiovascular problems. Stress also increases stimulant drug-seeking or drug-taking behavior by both humans and animals. In addition to the physiological effects on circulation, metabolism, and excretion, stress affects subject's responses to stimulant drugs such as MAP. However, the mechanisms underlying the drug-stress interactions remain unknown. In the present study, we assessed the effects of stress on myocardial responses to MAP in mice. Mice were injected with MAP (30 mg/kg) immediately before exposure to water-restraint stress (WRS), which has often been used as a stressor in animal experiments. The combination of MAP with WRS produced a significant increase (p < 0.01) in the leakage of proteins specific to myocardial damage and the levels of cytokines IL-6, TNF-α, and IL-10. The histological findings indicated the possibility that a combination of MAP with WRS induced cardiac myocytolysis. We also examined the expression of heat shock proteins (Hsps), which have cardioprotective effects. Administration of MAP alone significantly stimulated the RNA expressions of Hsp32, 60, 70, and 90 and the protein Hsp70 in cardiac muscles, whereas the expressions due to WRS or MAP plus WRS were not increased. These results reveal the fact that exposure to WRS depresses the induction of Hsps, in particular Hsp70, due to MAP injection, following to enhance MAP-induced myocardial damage. We believe that interactions between MAP and severe stress, including environmental temperature, affect the induction of Hsps, following to susceptibility of hosts to cardiotoxicity due to the stimulant drug.
AB - Methamphetamine (MAP) and stress both cause a variety of cardiovascular problems. Stress also increases stimulant drug-seeking or drug-taking behavior by both humans and animals. In addition to the physiological effects on circulation, metabolism, and excretion, stress affects subject's responses to stimulant drugs such as MAP. However, the mechanisms underlying the drug-stress interactions remain unknown. In the present study, we assessed the effects of stress on myocardial responses to MAP in mice. Mice were injected with MAP (30 mg/kg) immediately before exposure to water-restraint stress (WRS), which has often been used as a stressor in animal experiments. The combination of MAP with WRS produced a significant increase (p < 0.01) in the leakage of proteins specific to myocardial damage and the levels of cytokines IL-6, TNF-α, and IL-10. The histological findings indicated the possibility that a combination of MAP with WRS induced cardiac myocytolysis. We also examined the expression of heat shock proteins (Hsps), which have cardioprotective effects. Administration of MAP alone significantly stimulated the RNA expressions of Hsp32, 60, 70, and 90 and the protein Hsp70 in cardiac muscles, whereas the expressions due to WRS or MAP plus WRS were not increased. These results reveal the fact that exposure to WRS depresses the induction of Hsps, in particular Hsp70, due to MAP injection, following to enhance MAP-induced myocardial damage. We believe that interactions between MAP and severe stress, including environmental temperature, affect the induction of Hsps, following to susceptibility of hosts to cardiotoxicity due to the stimulant drug.
KW - Cardiotoxicity
KW - Heat shock protein
KW - Methamphetamine
KW - Myocardia
KW - Water-restraint stress
UR - http://www.scopus.com/inward/record.url?scp=79952699591&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952699591&partnerID=8YFLogxK
U2 - 10.1016/j.cbi.2011.01.025
DO - 10.1016/j.cbi.2011.01.025
M3 - Article
C2 - 21276779
AN - SCOPUS:79952699591
SN - 0009-2797
VL - 190
SP - 54
EP - 61
JO - Chemico-Biological Interactions
JF - Chemico-Biological Interactions
IS - 1
ER -